Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Clinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, China.
Front Endocrinol (Lausanne). 2022 Jul 28;13:952373. doi: 10.3389/fendo.2022.952373. eCollection 2022.
Long-term acupoint stimulation (LAS), also called embedding acupuncture, is a modified acupuncture technique. The preliminary results have demonstrated its efficacy in body-weight control. However, the low quality of available trials limited its application. This study aimed to evaluate the efficacy and safety of LAS in body-weight control by using a randomized, parallel, sham-controlled clinical trial design.
This was a randomized, single-blind, sham-controlled clinical trial including 84 adult participants (18-60 years) with a body mass index (BMI) of ≥ 24 kg/m conducted in three general hospitals in Shanghai, China. Participants were equally assigned to receive LAS or sham LAS (SLAS) once per 10 days, eight times in total. After completion, an additional intervention with a 3-month follow-up period was set to examine the continued effect of LAS. The primary outcome was the change in body weight from baseline to treatment endpoint within the intention-to-treat (ITT) analysis. Secondary outcomes contained changes in waist-to-hip ratio (WHR), lipid metabolism, and visceral and subcutaneous adipose tissues.
From 14 May 2018 to 03 November 2019, 84 participants out of 201 screened individuals met the eligibility criteria, were randomized, and were analyzed (42 participants in each group). From baseline to treatment endpoint, the body-weight reduction in the LAS group was significantly larger than in the sham control (net difference: 1.57 kg, 95% CI: 0.29-2.86, = 0.012). The superior weight reduction effect persisted in the follow-up period (net difference: 3.20 kg, 95% CI: 1.17-5.21, = 0.001). LAS therapy also showed improvement in triglyceride and subcutaneous adipose tissue (SAT) compared with sham control. One participant in the LAS group reported a slightly uncomfortable and tingling sensation after the additional intervention. No other adverse events (AEs) were documented.
LAS, a modified acupuncture technique, is safe and effective in body-weight control. It could be used as an alternative choice to classical acupuncture for obesity management.
[www.chictr.org.cn], identifier [ChiCTR1800015498].
长期穴位刺激(LAS),也称为埋针,是一种改良的针灸技术。初步结果表明其在体重控制方面具有疗效。然而,现有试验的质量较低限制了其应用。本研究旨在采用随机、平行、假对照临床试验设计,评估 LAS 在体重控制中的疗效和安全性。
这是一项在上海 3 家综合医院进行的成人参与者(18-60 岁)、BMI≥24kg/m2 的随机、单盲、假对照临床试验。参与者被平均分配接受 LAS 或假 LAS(SLAS),每 10 天一次,共 8 次。完成后,设置了一个额外的 3 个月随访期,以检查 LAS 的持续效果。主要结局是意向治疗(ITT)分析中从基线到治疗终点的体重变化。次要结局包括腰臀比(WHR)、脂代谢以及内脏和皮下脂肪组织的变化。
2018 年 5 月 14 日至 2019 年 11 月 3 日,从 201 名筛选出的个体中,84 名符合入选标准,被随机分组并进行分析(每组 42 名)。从基线到治疗终点,LAS 组的体重减轻明显大于假对照组(净差值:1.57kg,95%置信区间:0.29-2.86,=0.012)。在随访期间,体重减轻的效果仍然存在(净差值:3.20kg,95%置信区间:1.17-5.21,=0.001)。LAS 治疗与假对照相比,还改善了甘油三酯和皮下脂肪组织(SAT)。LAS 组有 1 名参与者在额外干预后报告了轻微的不适和刺痛感。未记录到其他不良事件(AE)。
LAS,一种改良的针灸技术,在体重控制方面是安全有效的。它可以作为肥胖管理中经典针灸的替代选择。
[www.chictr.org.cn],注册号 [ChiCTR1800015498]。